论文信息 - FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma - 字舞流文

FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma

Huanyu Chen | P. Keegan | R. Pazdur | Hong Zhao | R. Sridhara | M. Theoret | Yaning Wang | P. Mishra-Kalyani | A. Barone | Sriram Subramaniam | E. Pfuma | Hongshan Li | J. F. Zirkelbach | M. Hazarika | Kun He